Nobuyuki Hamanaka - Concepedia

Author

Nobuyuki Hamanaka

Ono Pharmaceutical (Japan)

Also Known As

Hamanaka, N., N Hamanaka, N. HAMANAKA, N. Hamanaka, NOBUYUKI HAMANAKA, Nobuyuki HAMANAKA, Nobuyuki Hamanaka

191

Publications

2.4K

Citations

H-Index

Concepts

All Affiliations

Ono Pharmaceutical (Japan)Hokkaido University Kyoto University Kanagawa Prefectural Hospital Organization Kanagawa Cancer Center

About

Nobuyuki Hamanaka is an author at Ono Pharmaceutical (Japan) specializing in pharmacology, medicine, and natural sciences.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	20	34	1.1K
2	Natural Sciences	17	28	800
3	Biochemistry	17	27	669
4	Engineering	11	11	302
5	Health Sciences	1	1	60

Nobuyuki Hamanaka

Publications

2.1K

Citations

H-Index

Page 1

	Year	Citations
Pharmacologic characterization of human and canine thromboxane A2/prostaglandin H2 receptors in platelets and blood vessels: evidence for different receptors. Dale E. Mais, D L Saussy, Amer Chaikhouni, Journal of Pharmacology and Experimental Therapeutics	1985	153
Enniatin has a new function as an inhibitor of Pdr5p, one of the ABC transporters in Saccharomyces cerevisiae Kazumi Hiraga, Shogo Yamamoto, Hiroyuki Fukuda, Biochemical and Biophysical Research Communications Molecular PharmacologySignal TransductionAbc TransportersSaccharomyces CerevisiaeMedicine	2005	112
Macrocarpals: HIV-RTase inhibitors of Eucalyptus globulus Mugio Nishizawa, Makoto Emura, Yukiko Kan, Tetrahedron Letters Hiv-rtase InhibitorsHuman RetrovirusAntiviral ResponseVirologyHiv	1992	99
Ruthenium(II)-catalyzed reactions of 1,4-epiperoxides Masaaki Suzuki, Hiroaki Ohtake, Yoshimi Kameya, The Journal of Organic Chemistry Inorganic ChemistryMolecular SciencesEngineeringAlkene MetathesisChemical Analysis	1989	92
Design, Synthesis, and Biological Evaluation of the Combinatorial Library with a New Spirodiketopiperazine Scaffold. Discovery of Novel Potent and Selective Low-Molecular-Weight CCR5 Antagonists Hiromu Habashita, Masaya Kokubo, Shin-ichi Hamano, Journal of Medicinal Chemistry Combinatorial ChemistryDrug TargetPharmacotherapyChemical BiologyPharmaceutical Chemistry	2006	79
Ultrasonographic detection of early and curable carcinoma of the gallbladder Akitoshi Koga, Shoichiro Yamauchi, Yasuharu Izumi, British journal of surgery Early CarcinomaUltrasonographic DetectionEus-guided Gallbladder DrainageMedical ImagingGallbladder Wall	1985	60
In vitro and in vivo effects of new powerful thromboxane antagonists (3-alkylamino pinane derivatives). Masashi Katsura, T. MIYAMOTO, Nobuyuki Hamanaka, PubMed ThrombosisMolecular PharmacologyPharmacologyCardiovascular Pharmacology3-Alkylamino Pinane Derivatives	1983	60
High Expression of Integrin β1 and p53 is a Greater Poor Prognostic Factor Than Clinical Stage in Small-Cell Lung Cancer Fumihiro Oshita, Yoichi Kameda, Nobuyuki Hamanaka, American Journal of Clinical Oncology Integrin β1ImmunologyPathologyCancer BiologyTumor Biology	2004	53
Conformational study of a highly specific CXCR4 inhibitor, T140, disclosing the close proximity of its intrinsic pharmacophores associated with strong anti-HIV activity Hirokazu Tamamura, Makiko Sugioka, Yoshihiko Odagaki, Bioorganic & Medicinal Chemistry Letters Medicinal ChemistryMedicineHuman RetrovirusImmunologyStrong Anti-hiv Activity	2001	52
Diastereoselective Synthesis of New <i>ψ</i>[(<i>E</i>)-CHCMe]- and <i>ψ</i>[(<i>Z</i>)-CHCMe]-type Alkene Dipeptide Isosteres by Organocopper Reagents and Application to Conformationally Restricted Cyclic RGD Peptidomimetics Shinya Oishi, Takae Kamano, Ayumu Niida, The Journal of Organic Chemistry	2002	51

Page 1